The EIC Accelerator is a highly competitive grant program that supports innovative startups, including those in the biotech and AI sectors. The venture's focus on predicting drug resistance mutations from protein sequence alone aligns well with the program's emphasis on cutting-edge technology. With a continuous application process and multiple evaluation batches per year, this opportunity is a strong fit for the venture's current stage and goals.